Efficacy News and Research

RSS

Omicron binds to ACE2 with high affinity, enhancing its transmissibility and infectivity

...

8 Dec 2021

Study shows how senescent cells can be an underlying cause of kidney damage

A study in mice by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that stress and tissue damage initiated by angiotensin II, a molecule that is known to increase blood pressure and stiffening in the linings of blood vessels, leads to cellular senescence, a process by which a cell ages and permanently stops dividing but does not die.

8 Dec 2021

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

New research reports 4’-Fluorouridine (4′-FlU) as an oral antiviral against RSV and SARS-CoV-2.

7 Dec 2021

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

A recent review looks at the molecular design of pH-sensitive cationic lipids and their applications for various tissues and cell types.

7 Dec 2021

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Scientists develop an improved biosensor with Cas12a-based CRISPR on-site rapid detection system and discuss its ability to detect SARS-CoV-2 VOCs.

7 Dec 2021

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination.

7 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach.

7 Dec 2021

Combination of prior infection and vaccination produces a more potent defense against SARS-CoV-2

Antibodies against the SARS-CoV-2 spike protein produced by the immune system can help identify and fend off future infections, but not all antibodies are the same.

7 Dec 2021

Impact of infection control measures and vaccines in protecting healthcare workers from COVID-19

New study findings highlight the importance of COVID-19 vaccination in reducing the risk of infection among healthcare workers.

7 Dec 2021

‘Moving molecule’ therapy for severe spinal cord injury

In this interview, News-Medical speaks to Dr. Stupp about his recent research into a therapy involving dancing molecules for the treatment of severe spinal cord injury.

7 Dec 2021

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

A new study indicates an immunological response to SARS-CoV-2 vaccines in immunosuppressed patients that were comparable to healthy patients.

7 Dec 2021

Immune response of Pfizer vaccinees who received Moderna or Pfizer booster

A new preprint discusses the immune boost resulting from homologous or heterologous booster doses in individuals fully vaccinated with two doses of the Pfizer vaccine.

7 Dec 2021

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

6 Dec 2021

Study shows COVID booster shots work

A new study investigates uses seven different COVID-19 vaccines as the third dose to boost immunity in vulnerable patients.

6 Dec 2021

Youth violence prevention program can be integrated into emergency and primary care settings

Opportunities to reach teens who are at risk for violence and substance use are rare. There may be only a small window of time to prevent often life-threatening violent injuries.

6 Dec 2021

SARS-CoV-2 immune memory in mRNA vaccine recipients

Researchers measured SARS-CoV-2–specific antibody, memory B cell, and memory T cell responses in a group of healthy subjects who generated primary immune responses to two doses of mRNA vaccine compared to a group of SARS-CoV-2–recovered vaccines.

6 Dec 2021

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

A study recently published in the journal JAMA Oncology has stated that coronavirus disease 2019 (COVID-19) vaccines are more than 55% effective in reducing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer patients.

5 Dec 2021

Strict COVID anti-contagion policies can provide long-term health benefits

Researchers assess the short- and long-term benefits of these policies on health outcomes in the Chinese population.

5 Dec 2021

The emergence and evolution of SARS-CoV-2 and its VOCs

A review article discusses the evolution of SARS-CoV-2 and the emergence of variants of concern.

5 Dec 2021

Efficacy News and Research

Omicron binds to ACE2 with high affinity, enhancing its transmissibility and infectivity

Study shows how senescent cells can be an underlying cause of kidney damage

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

Combination of prior infection and vaccination produces a more potent defense against SARS-CoV-2

Impact of infection control measures and vaccines in protecting healthcare workers from COVID-19

‘Moving molecule’ therapy for severe spinal cord injury

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

Immune response of Pfizer vaccinees who received Moderna or Pfizer booster

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

Study shows COVID booster shots work

Youth violence prevention program can be integrated into emergency and primary care settings

SARS-CoV-2 immune memory in mRNA vaccine recipients

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

Strict COVID anti-contagion policies can provide long-term health benefits

The emergence and evolution of SARS-CoV-2 and its VOCs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News